In this study, using bio-based eugenol as the basic polymerization unit, the directional coupling of quaternary phosphonium cations and eugenol was achieved through covalent bonding, and a new type of degradable antibacterial monomer (Eu-PH) was successfully synthesized. Notably, cubic nanoparticles were obtained via the self-assembly of Eu-PH during its homopolymerization, whereas spherical nanoparticles were generated when Eu-PH was copolymerized with N-vinylpyrrolidone (NVP). This structural transformation not only induced significant changes in the material's physicochemical properties but also markedly enhanced its antibacterial efficacy. Experimental results demonstrated that PHx-PVPy achieved inhibition rates of 100% against Escherichia coli and Staphylococcus aureus, with a relative biocompatibility of 99% toward L-929 cells. In addition, PHx-PVPy exhibited excellent degradability and fruit preservation performance. In brief, by virtue of structural regulation of bio-based eugenol and NVP, a promising new approach is proposed for the development of antibacterial materials that simultaneously possess high antibacterial activity, good biocompatibility, and satisfactory degradability.
Sun et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: